Business profile

Shuaibi Medics Oy

Shuaibi Medics Oy's registered office is Helsingfors. It is a limited company. The company was established on 2021-03-03. It operates in the industry of general medical practice activities. In its latest retained statement for 2025-12-31, revenue was €107,601 and operating profit was €39,486.

Claim profileContact details
Business ID 3192872-5ValidUnclaimed company profile

Trusted core data

Public company details from the trade register.

Business ID
3192872-5
Sector
General medical practice activities
Municipality
Helsingfors
Company form
Limited company
Registration date
2021-03-03
Business ID registration date
2021-02-22
Business status
Valid
Profile ownership
Unclaimed company profile

Contact and location summary

Visiting address: Tankomäenkatu 3 C 44, 00950, Helsingfors

About Shuaibi Medics Oy

Financial position and key figures for the company.

Shuaibi Medics Oy's location municipality is Helsingfors. It is a limited company. The company was established on 2021-03-03. It operates in the industry of general medical practice activities. In its latest retained statement for 2025-12-31, revenue was €107,601 and operating profit was €39,486. The latest retained financial statement for 2025-12-31 shows revenue of €107,601 and profit for the financial year of €38,150. Based on the latest retained statement, revenue growth was +1744.7%, operating margin was +36.7%, and equity ratio was +89.7%.

Financial highlights

Key figures from the latest financial period.

Open full statement
Latest financial period

2025-12-31

Imported periods5
PRH parsed3
Profile sourcePRH/XBRL financial statement
Derived indicators
Revenue growth1744.7%
Operating margin36.7%
Equity ratio89.7%
Balance-sheet contextLatest financial period
Other operating income€1,727Previous: €0
Cash and bank€20,920Previous: €6,290
Retained earnings€39,914Previous: €39,008
Equity€78,064Previous: €43,385
Liabilities€8,993Previous: €15,939
Current assets€76,860Previous: €14,071
Current liabilities€8,993Previous: €15,939
Revenue trend3 periods
€30,535
2023-12-31
€5,833
2024-12-31
€107,601
2025-12-31
Operating profit (loss) trend3 periods
-€13,411
2023-12-31
-€13,765
2024-12-31
€39,486
2025-12-31
Profit (loss) for the financial year trend3 periods
-€15,790
2023-12-31
€4,377
2024-12-31
€38,150
2025-12-31
Assets trend3 periods
€42,783
2023-12-31
€59,324
2024-12-31
€87,057
2025-12-31

Financial ratios

Financial ratios based on financial statement data. Source: PRH/XBRL-tilinpäätös.

Equity ratioGood
100/100 · Improving
89.7 %2024-12-31: 73.1 %
Current ratioGood
78/100 · Improving
2.33x2024-12-31: 0.39x
Operating profit marginGood
100/100 · Improving
36.1 %2024-12-31: -236.0 %
Ratio history
Ratio2023-12-312024-12-312025-12-31
Equity ratio99.1 %73.1 %89.7 %
Current ratio2.99x0.39x2.33x
Operating profit margin-43.9 %-236.0 %36.1 %

Registry status and identifiers

Current registry information and identifiers based on YTJ data.

YTJ statusValid
Trade RegisterRegistered
Business ID3192872-5
EU IDFIFPRO.3192872-5
MunicipalityHelsingfors
Current registered entries
2021-03-03Registered in Tax Administration (Tax Administration)
2021-03-03Registered in Patent and Registration Office (Trade Register)
2021-03-15Registered in Tax Administration (Prepayment Register)

Risk certificate

An open-data based company stability and risk signal.

BUSINESS.fi

BUSINESS.fi Luottoluokitus

Profile-specific risk signal based on open data

Automatic gradeNot a credit decision
A1
ExcellentShuaibi Medics Oy
Grade upgradedB2 → A1 · new analysis 2026-11-09
Model score90/100
Assessment confidenceHigh
Evidence qualityStrong financial evidenceFinancial data included
Financial trajectoryFinancial development has been volatile across multiple domains.
3 comparable periods
RevenueVolatile
ProfitabilityVolatile
SolvencyVolatile
LiquidityVolatile
Peer comparisonSame industry, size and age groupDescriptive comparison – does not change the model score.
89 peers
Solvency55%
Better than 55% of peers
Profitability62%
Better than 62% of peers
Liquidity52%
Close to the peer-group midpoint
Revenue growth100%
Better than 100% of peers
Financial statement reporting patternMixedBased on observed PRH financial period end and registration dates. This descriptive evidence does not change the v0.14 score.
4 observed filings
Latest registration lag293 days after period end
Typical registration lag259 days after period end
Annual continuity4 consecutive periods
Supporting factors
  • Strong equity ratio
  • Strong operating profitability
  • Healthy short-term liquidity
Risk factors to note
  • Material volatility across multiple financial domains
Rating historyAutomatic assessment developmentChanges are derived from evidence differences between persisted automatic assessments.
6 assessments
A1
2026-11-09 19:4690/100 · v0.15
B2 → A1 · +36 points
  • Evidence strengthened: a newer PRH/XBRL financial statement was added to the assessment (2025-12-31).
B2
2026-10-1854/100 · v0.15
B2 → B2
B2
2026-09-25 14:2554/100 · v0.14
A3 → B2 · -16 points
  • Evidence strengthened: a PRH/XBRL financial statement was added to the assessment (2024-12-31).
  • Assessment confidence: Medium → High.
  • Evidence quality: Registry and statistical evidence → Strong financial evidence.
A3
2026-09-1570/100 · v0.14
Oldest retained automatic assessment in this comparison
Automatic model gradeA1
Automatic model snapshot2026-11-09
Automatic model versionopen-risk-grade-v0.15
Financial data included

The grade can use open digital financial statement data together with registry signals.

Verify assessment

Risk context

When sufficient source-backed financial metrics are not available for a Tier 1 assessment, BUSINESS.fi shows registry, industry, and regional context.

Industry riskvery low
94/100

Industry context is very low based on normalized open statistical inputs.

Age and continuityHyvä
60/100

The company has about 5 years of registry continuity.

Registry and status signalsRajallinen
51/100

Registry history, filing recency, and active register markings are still limited or mixed.

Events & news

Verified events and sourced external company news in one timeline.

Risk grade updatedRisk gradeEvidence verified
9 Nov 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B2 → A1.
Financial statement availableFinancialEvidence verified
20 Oct 2026 · PRH / XBRLFinancial period ends 2025-12-31.
Risk grade updatedRisk gradeEvidence verified
18 Oct 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B2.
Risk grade updatedRisk gradeEvidence verified
25 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3 → B2.
Risk grade updatedRisk gradeEvidence verified
15 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade A3.
Risk grade updatedRisk gradeEvidence verified
14 Sept 2026 · BUSINESS.fi / Opterom LuottoluokitusAutomatic grade B1.

Registry timeline

Trade register notifications shown on a timeline.

7 register eventsLatest event: 2025-10-18

Financial statements availability

Available financial statement periods and PRH source filings.

5 financial statement periodsLatest financial period: 2025-12-31

Profile source and ownership

Profile based on public registry data
BUSINESS.fi has created this profile from public company information. Source data updated 2025-12-31.

This company profile has not been claimed yet

Shuaibi Medics Oy shows public core facts. A company representative can claim the profile, update public information, and access owner tools.